Back to search
Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) trials you may qualify forThe objective of the Pediatric Epidemiological Data and Incidence (PEDI) PANDAS study is to demonstrate the feasibility of enrollment and retention of subjects…
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle in…
This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a co…
Open-label prospective trial to study efficacy, safety and tolerability of intravenous immunoglobulin (IVIG) once monthly for 6 months in children and adolescen…
A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome
The Economic Impact Study of IVIG treatment for PANS is a part of the Unhide™ Project, which is a research initiative developed by the Brain Inflammation Collab…